Suspicious for Malignancy
The majority of thyroid nodules are benign, but a small percentage, about 10–15%, are malignant. According to The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC), 3% of all thyroid fine needle aspiration (FNA) specimens are classified as Suspicious for Malignancy (SM).
KeywordsSuspicious for malignancy Suspicious for papillary thyroid carcinoma PTC Suspicious for medullary thyroid carcinoma MTC Suspicious for lymphoma Immunocytochemistry Suspicious for malignancy not otherwise specified
- 8.Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016;26:1–133. https://doi.org/10.1089/thy.2015.0020. Review.CrossRefGoogle Scholar
- 14.Luu MH, Fischer AH, Pisharodi L, Owens CL. Improved preoperative definitive diagnosis of papillary thyroid carcinoma in FNAs prepared with both ThinPrep and conventional smears compared with FNAs prepared with ThinPrep alone. Cancer Cytopathol. 2011;119:68–73. https://doi.org/10.1002/cncy.20124.CrossRefPubMedPubMedCentralGoogle Scholar
- 16.Nikiforov YE, Biddinger PW, Thompson LDR. Diagnostic pathology and molecular genetics of the thyroid: a comprehensive guide for practicing thyroid pathology. 3rd ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 2019.Google Scholar
- 18.Rekhtman N, Buonocore DJ, Rudomina D, Friedlander M, Dsouza C, Aggarwal G, et al. Novel modification of HistoGel-based cell block preparation method: improved sufficiency for molecular studies. Arch Pathol Lab Med. 2018;142:529–35. https://doi.org/10.5858/arpa.2017-0030-OA.CrossRefPubMedGoogle Scholar